ArticleAmerican journal of cancer research2023

IRG1/Itaconate induces metabolic reprogramming to suppress ER-positive breast cancer cell growth.

Hsueh-Chun Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.